Recently, the fibrinogen like protein 1 (FGL-1) that is naturally expressed by liver cells and overexpressed by some tumor cells, was also characterized as a new ligand for LAG-3 which can potently prevent T cell activation upon binding (4). Here, LAG3 is linked to neoplasm.